Statements and Responses

Read GLADD's Rapid Response to a BMJ article about the Cass Review. GLADD's full response to the Cass Review is still being carefully made and will be released in due course.

Read GLADD's response to the Government's use of emergency powers in the Medical Act 1968 to ban private prescriptions of GnRH Analogues for young people experiencing Gender Dysphoria.

Read GLADD's statement on the GMC's apology for regulatory action taken against doctors under historic homophobic laws.

Read GLADD's statement regarding the decision for the CANSG conference hosted by the Royal College of General Practitioners (RCGP) on 23rd March 2024.

Read GLADD's original statement regarding the original concerns about the CANSG conference hosted at the RCGP.

Read GLADD's statement on the withdrawal of funding to the NHS Rainbow Badges project, a project GLADD has been proud to be a partner organisation of.

Read GLADD's statement regarding transphobic comments made at the 2023 Conservative Party Conference.

Read GLADD's Rapid Response to a BMJ article about banning Conversion Therapy for trans people.

GLADD and our colleagues at PRiSM (Pride in Surgery Forum) wrote and published a joint letter to the BMJ regarding an article published on Gender Dysphoria in young people. The BMJ was offered a chance to reply before we published this letter, but it was made clear by the BMJ that no apology would be made for the article.

After GLADD and PRiSM wrote to the BMJ, Emma Runswick, deputy chair of the BMA Council, published this piece, challenging the BMJ on the article.

Read a brief statement from GLADD regarding a problematic question in the MRCS Paper A in Autumn 2022.

GLADD wrote a letter to the BMJ following the High Court ruling on Bell v Tavistock to express concerns regarding the impact of the ruling on trans people's access to healthcare.

Following the High Court's judgement in Bell v. Tavistock, GLADD released this statement outlining our concerns of the impact on the wellbeing of young trans people, access to gender identity services, and the inadequate representation of trans and non-binary people in the decision-making process.